Legislation
Tougher Penalties for Counterfeiters Under Consideration
On June 4, Rep. Steve J. Israel (D-NY) introduced the Counterfeit Enforcement Act of 2009 (H.R. 2726). This proposed legislation, which would amend the Federal Food, Drug and Cosmetic Act, increases penalties for the sale of contraband or counterfeit drugs. If passed, this legislation brings to life many of the ideas that the Partnership for Safe Medicines advocates in the Principles for Drug Safety.
[...]Congress on the Right Road to Stop Drug Counterfeiters
Earlier this year, Reps. John D. Dingell (D-MI 15), Frank Pallone, Jr. (D-NJ 06) and Bart Stupak (D-MI 01) introduced the Food and Drug Administration Globalization Act of 2009 (H.R.759). This legislation indicates that Congress is fbeginning an important journey to address several real threats that substandard and counterfeit drugs pose to the pharmaceutical supply chain.
[...]To Import or Not To Import
That is the question that many of our lawmakers are asking. Senators Dorgan (D-ND), Snowe (R-ME), McCain (R-AZ) and Stabenow (D-MI) brought that question to the forefront when they introduced the “Pharmaceutical Market Access and Drug Safety Act of 2009” (S. 525) in March. Currently waiting to be placed on the Senate calendar, the bill would allow for prescription drug importation.
[...]Letter to President Barack Obama
April 8, 2009 President Barack Obama1600 Pennsylvania Avenue, NWWashington, DC 20500 Dear Mr. President, On behalf of the Partnership for Safe Medicines (PSM), a group of organizations and individuals that have policies, procedures, or programs to protect consumers from counterfeit or contraband medicines and dedicated to the safety of the drug supply, I would like…
[...]Strategizing for Safety from Counterfeit Drugs
On April 6, the Office of the U.S. Trade Representative (USTR) released a summary of negotiations that have taken place since the Anti-Counterfeiting Trade Agreement (ACTA) was introduced in June 2008. Countries from across the world, including the United States, Australia, Canada, the European Union, Japan, Mexico, Morocco, New Zealand, Singapore, South Korea and Switzerland, have joined the ACTA to help governments combat the harmful manufacture and distribution of fake goods, such as counterfeit drugs.
[...]Drug Importation: Small Savings at a Large Cost
Supporters of drug importation like to cite the statistic that if the United States were to permit drug importation, it would reduce total drug spending by $40 billion over 10 years. This figure is from the 2004 Congressional Budget Office (CBO) issue brief on drug importation.
[...]International Cooperation Halts Counterfeit Drug Distribution Via Online Pharmacies
International cooperation is essential to curbing the widespread illicit sale of substandard, unapproved and counterfeit drugs. Another essential step is shutting down rogue online pharmacies.
[...]Kenya Fights Counterfeit Drugs
Counterfeit drugs are a scourge that spans continents and patients everywhere. Sadly however, some of the most vulnerable countries such as Kenya have been deeply impacted by the problem. The World Health Organization reports that a survey performed by the National Quality Control Laboratories and the Pharmacy and Poisons Board found that almost 30 percent of drugs in Kenya are counterfeit, harming thousands of patients and representing a tremendous public health problem. In addition, a 2006 estimate indicates that counterfeit drug sales account for approximately $130 million annually in sales. Importantly, these fakes are believed to contribute to at least 200,000 of the 2.7 million deaths caused by malaria each year in Africa.
Who’s Accountable
Ryan Haight. Marcia Bergeron. They paid with their wallets for diverted and counterfeit drugs. They also paid with their lives.
[...]